Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
JAK1 |
Janus kinase 1 |
FXC01306
|
FHC01306
|
FNC01306N
|
FNC01306C
|
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
FXC01313
|
FHC01313
|
FNC01313N
|
FNC01313C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor), transcript variant 2 |
FXC01466
|
FHC01466
|
FNC01466N
|
FNC01466C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific, transcript variant 2 |
FXC01544
|
FHC01544
|
FNC01544N
|
FNC01544C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
FXC02618
|
FHC02618
|
FNC02618N
|
FNC02618C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
BCL2L1 |
BCL2-like 1, transcript variant 1 |
FXC03091
|
FHC03091
|
FNC03091N
|
FNC03091C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant 1 |
FXC04167
|
FHC04167
|
FNC04167N
|
FNC04167C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
RALBP1 |
ralA binding protein 1 |
FXC08672
|
FHC08672
|
FNC08672N
|
FNC08672C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
RAD51 |
RAD51 recombinase, transcript variant 1 |
FXC10574
|
FHC10574
|
FNC10574N
|
FNC10574C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
TGFA |
transforming growth factor, alpha |
FXC10823
|
FHC10823
|
FNC10823N
|
FNC10823C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
FXC11836
|
FHC11836
|
FNC11836N
|
FNC11836C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
FXC21157
|
FHC21157
|
FNC21157N
|
FNC21157C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
BRCA2 |
BRCA2, DNA repair associated |
FXC24976
|
FHC24976
|
FNC24976N
|
FNC24976C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|